fmp010
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2008 (NCT00666380)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fmp010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00666380 | Phase 1 | Apr 1, 2008 | GlaxoSmithKline, Kenya Medical Research Institute, United States Agency for International Development, United States Army |
| NCT02458092 | Phase 1 | Apr 1, 2008 | GlaxoSmithKline, Kenya Medical Research Institute, United States Agency for International Development, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 0 | 1 | 2008 |
| Kenya Medical Research Institute | Academic/Hospital | 2 | 0 | 1 | 2008 |
| United States Agency for International Development | Government | 2 | 0 | 1 | 2008 |
| United States Army | Government | 2 | 2 | 1 | 2008 |
4 organizations
Page 1 / 1